Arylindenopyridines and arylindenopyrimidines and their use as adenosine A2A receptor antogonist

摘要

Disclosed is a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of the compound of formula I in the preparation of a pharmaceutical composition for the preparation of a medicament for treating a disorder ameliorated by antagonizing Adenosine A2a receptors such as Parkinson's Disease, Huntington's Disease and Senile Dementia. (62) Divided Out of 546212